Skip to main content
Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

1 Aufruf
Herunterladen
Pharmazeutisch

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.

Dosierung

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Stärke

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Packungsgröße

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Form

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Sicherheitsprofil

Kontraindikationen

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Nebenwirkungen

Public statement on Eperzan: Withdrawal of the marketing authorisation in the European Union

Verwandte klinische Artikel

Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.

QR Code